BIOR - BIORA THERAPEUTICS, INC.
0.5461
-0.214 -39.169%
Share volume: 0
Last Updated: Tue 10 Dec 2024 09:29:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$0.76
-0.21
-28.14%
Summary score
34%
Profitability
50%
Dept financing
43%
Liquidity
13%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
28.29%
Return on assets
-32.92%
Return on sales
-154495.35%
Return on invested capital
86.06%
Total debt ratio
299.66%
Debt ratio change over timeo
6.9%
Current Ratio
1.13%
Quick Ratio
1.12%
Cash Position Ratio
0.88%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
23.99%
Return on assets
-51.88%
Return on sales
-374781.37%
Return on invested capital
64.36%
Total debt ratio
436.58%
Debt ratio change over timeo
16.33%
Current Ratio
0.44%
Quick Ratio
0.44%
Cash Position Ratio
0.33%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
4.18%
Return on assets
-67.49%
Return on sales
-2862.73%
Return on invested capital
9.93%
Total debt ratio
535.78%
Debt ratio change over time
16.67%
Current Ratio
0.28%
Quick Ratio
0.28%
Cash Position Ratio
0.21%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-39.51%
Return on assets
-183.5%
Return on sales
-216472.79%
Return on invested capital
47.14%
Total debt ratio
689.86%
Debt ratio change over time
6.9%
Current Ratio
1.17%
Quick Ratio
1.16%
Cash Position Ratio
0.74%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BIOR | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 28.29% | 13.03% | 18.15% | 6.63% |
| Return on assets | -32.92% | 2.33% | 3.24% | 5.84% |
| Return on sales | -154495.35% | 28.06% | 32.46% | 43.41% |
| Return on invested capital | 86.06% | 2.07% | 5.53% | 34.89% |
| Profitability | 50% | 38% | 50% | 66% |
| Total debt ratio | 299.66% | 90.46% | 90.54% | 24.67% |
| Debt ratio change over time | 6.9% | 435.59% | 17.23% | -0.06% |
| Dept financing | 25% | 33% | 9% | 2% |
| Current Ratio | 0.44% | 0.9% | 1.54% | 3.64% |
| Quick Ratio | 0.44% | 0.8% | 1.06% | 3.42% |
| Cash Position Ratio | 0.33% | 0.39% | 0.54% | 2.77% |
| Liquididy | 20% | 13% | 28% | 75% |
| Short-term ratios | BIOR | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 23.99% | 0% | 0% | 5.91% |
| Return on assets | -51.88% | 1.33% | 1.27% | 4.97% |
| Return on sales | -374781.37% | 22.54% | 14.41% | 42.59% |
| Return on invested capital | 64.36% | 0% | 0% | 23.7% |
| Profitability | 50% | 20% | 15% | 65% |
| Total debt ratio | 436.58% | 93.47% | 94.09% | 24.56% |
| Debt ratio change over time | 16.33% | 0% | 0% | -0.62% |
| Dept financing | 50% | 5% | 5% | 1% |
| Current Ratio | 0.44% | 0.9% | 1.54% | 3.64% |
| Quick Ratio | 0.44% | 0.8% | 1.06% | 3.42% |
| Cash Position Ratio | 0.33% | 0.39% | 0.54% | 2.77% |
| Liquididy | 9% | 16% | 23% | 75% |